Multiple Myeloma News and Research

Latest Multiple Myeloma News and Research

Depressive symptoms linked to early death in cancer survivors

Depressive symptoms linked to early death in cancer survivors

Loyola opens 20-bed unit for patients undergoing stem cell transplants for cancers

Loyola opens 20-bed unit for patients undergoing stem cell transplants for cancers

Entremed reports patent issuance for its lead drug candidate ENMD-2076

Entremed reports patent issuance for its lead drug candidate ENMD-2076

Single antibody could be key to treating multiple myeloma

Single antibody could be key to treating multiple myeloma

EntreMed announces issuance of patent for clinical-stage compound, 2-methoxyestradiol

EntreMed announces issuance of patent for clinical-stage compound, 2-methoxyestradiol

Researchers identify how proteasome takes care of unwanted, potentially toxic proteins

Researchers identify how proteasome takes care of unwanted, potentially toxic proteins

Senesco completes cohort 2 in Phase 1b/2a clinical study of SNS01-T

Senesco completes cohort 2 in Phase 1b/2a clinical study of SNS01-T

BioInvent starts BI-505 phase II study in patients with smoldering multiple myeloma

BioInvent starts BI-505 phase II study in patients with smoldering multiple myeloma

Enrollment for Pharmacyclics' Phase III study using ibrutinib in CLL patients completed

Enrollment for Pharmacyclics' Phase III study using ibrutinib in CLL patients completed

New pre-clinical study suggests novel drug combination therapy for leukemia treatment

New pre-clinical study suggests novel drug combination therapy for leukemia treatment

Preclinical data on anti-cancer activity of BI-505 published online in Cancer Cell

Preclinical data on anti-cancer activity of BI-505 published online in Cancer Cell

Pharmacyclics presents positive results of ibrutinib Phase II trial in untreated, relapsed and refractory CLL patients

Pharmacyclics presents positive results of ibrutinib Phase II trial in untreated, relapsed and refractory CLL patients

BioLineRx gets regulatory approvals in US to start BL-8040 Phase IIa trial for treatment of AML

BioLineRx gets regulatory approvals in US to start BL-8040 Phase IIa trial for treatment of AML

Study: Chicken-killing virus is a promising treatment for prostate cancer

Study: Chicken-killing virus is a promising treatment for prostate cancer

FDA grants Breakthrough Therapy Designation for ibrutinib as monotherapy for CLL patients

FDA grants Breakthrough Therapy Designation for ibrutinib as monotherapy for CLL patients

BioInvent International presents clinical results of BI-505 at myeloma workshop in Kyoto

BioInvent International presents clinical results of BI-505 at myeloma workshop in Kyoto

TGen to present scientific benefits of whole genome sequencing at myeloma workshop

TGen to present scientific benefits of whole genome sequencing at myeloma workshop

Researchers develop new guidelines to treat recently diagnosed multiple myeloma patients

Researchers develop new guidelines to treat recently diagnosed multiple myeloma patients

Phase II trial results of OHR/AVR118 in patients with cancer cachexia announced

Phase II trial results of OHR/AVR118 in patients with cancer cachexia announced

TGen to present latest research about multiple myeloma at free public conference

TGen to present latest research about multiple myeloma at free public conference

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.